N-substituted benzamides inhibit nuclear factor-kappa B and nuclear factorof activated T cells activity while inducing activator protein 1 activity in T lymphocytes
H. Lindgren et al., N-substituted benzamides inhibit nuclear factor-kappa B and nuclear factorof activated T cells activity while inducing activator protein 1 activity in T lymphocytes, MOL IMMUNOL, 38(4), 2001, pp. 267-277
N-substituted benzamides are compounds that have recently been reported to
inhibit nuclear factor-kappaB (NF-kappaB) activity and induce apoptosis in
a pre-B cell line. In this study. we focused on the effects of N-substitute
d benzamides on transcriptional regulation in Jurkat T cells. We used a mod
el system where the cells can be stimulated either through TCR/CD28 or by t
reatment of the cells with PMA and ionomycin to induce transcription factor
s typical for T lymphocyte activation. Treatment of the Jurkat cells with p
rocainamide did not influence the transcription factor profile of stimulate
d cells, while treatment with a derivative having an acetyl group in positi
on 4 of the aromatic ring inhibited NF-kappaB and nuclear factor of activat
ed T cells (NFAT) activity. Declopramide, which contains a chloride in posi
tion 3 of the aromatic ring, was inactive in this system, whereas also the
acetylated derivative of this compound inhibited NF-kappaB and NFAT activit
y. In contrast, the transcriptional activity and nuclear expression of acti
vator protein I induced by TCR/CD28 stimulation or PMA and ionomycin treatm
ent was enhanced by the acetylated variants of the N-substituted benzamides
. Finally, we investigated the effect of N-substituted benzamides on intact
promoters for two genes central in immune regulation; the CD40 ligand (CD4
0L) and IL-2 promoters. The transcriptional activity of the CD40L promoter
as well as surface expression of the CD40L induced by signaling through TCR
/CD28 was inhibited by addition of acetylated N-substituted benzamides, whi
le the transcriptional activity of the IL-2 promoter was enhanced. Taken to
gether, these data indicate that derivatives of N-substituted benzamides ar
e potential drug candidates for quantitative as well as qualitative modulat
ion of immune functions. (C) 2001 Elsevier Science Ltd. All rights reserved
.